Single-Tablet Dolutegravir-Based Therapy for HIV-infected Women Single-Tablet Dolutegravir-Based Therapy for HIV-infected Women

A single-tablet dolutegravir-based combination regimen given daily is noninferior to a multi-pill atazanavir-based regimen in previously untreated women with HIV infection, and has a similar safety profile.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news